ERDERA Joint Transnational Call for Proposals on Rare Disease Therapies
The European Rare Diseases Research Alliance (ERDERA) launched its Joint Transnational Call (JTC) for Proposals 2025 on December 10, 2024. This call invites research teams from across Europe and beyond to submit collaborative projects focused on “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation”.
Topics of Interest
Eligible proposals may include research on:
- Development of pre-clinical therapies using cell, organoid, or animal models.
- Biomarker identification that correlates with therapeutic efficacy.
- Pre-clinical proof-of-concept studies showing pharmacological activity and safety data.
Notably, gene therapies, rare neurodegenerative diseases like Alzheimer’s, and rare cancers are excluded from this call. Projects should have a special focus on therapies that can translate into clinical applications.
Application Timeline
The JTC 2025 will follow a two-stage submission process:
13 February 2025 | Deadline for pre-proposal submission |
9 June 2025 | Deadline for full-proposal submission. Funding decisions are expected by December 2025. |
EP PerMed JTC2025 Pre-announcement – Pharmacogenomic Strategies for Personalised Medicine (PGxPM2025)
The European Partnership for Personalised Medicine, EP PerMed (supported by the European Union under Horizon Europe, Grant Agreement N° 101137129), is a platform for joint programming of national and European regional research and innovation supporting activities putting into action “The Strategic Research & Innovation Agenda (SRIA) for Personalised Medicine (2023)” , SRIA for PM (2023), through dedicated research, development and innovation funding.
EP PerMed funding organisations have agreed to launch the joint transnational call 2025 (JTC2025), co-funded by the EU, to fund multinational innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe in this field. The JTC2025 will be conducted simultaneously by the participating funding organisations in their respective region/country and coordinated centrally by the Joint Call Secretariat (JCS), hosted by the German Aerospace Center e.V. – Project Management Agency, (DLR-PT), Germany.
The call will be implemented in two stages, i.e. a pre- and a full-proposal phase. The available budget for this call is 35 Mio. € (approx.).
An information day introducing the JTC2025 to the research community will be organised most probably on January 09, 2025. More details (including the registration) will follow soon.
18 February 2025 (14:00 CET) | Deadline for pre-proposal submission |
17 June 2025 (14:00, CEST) | Deadline for full-proposal submission |
IHI call 9&10
Call 9
The submission deadline for full proposals (FPs) will be 29 April 2025.
Topics:
- Boosting innovation for a better understanding of the determinants of health
- Boosting innovation through better integration of fragmented health R&I efforts
- Boosting innovation for peopled centred integrated healthcare solutions
- Boosting innovation through exploitation of digitalisation and data exchange in healthcare
- Boosting innovation through exploitation of digitalisation and data exchange in healthcare
29 April 2025 | Deadline for full-proposal submission |
Call 10
The submission deadline for short proposals (SPs) will be 23 April 2025 and the full proposals (FPs) submission deadline will be 14 October 2025.
Topics:
- Digital label: one source of comprehensive information for medical technology products
- Enabling and safeguarding innovation in secondary use of health data in the European Health Data Space (EHDS)
- Per- and Poly-fluoroalkyl substance (PFAS) exposure, emissions, and end of life management in the healthcare sector
23 April 2025 | Deadline for short proposal submission |
14 October 2025 | Deadline for full-proposal submission |
Call for proposals on advancing the adoption of artificial intelligence in health (DI-g-24-76)
Deadline date : 22 January 2025.
The action is expected to:
a) create communities of experts with knowledge and experience on AI deployment in clinical settings;
b) identify challenges and accelerators of the safe and effective deployment of AI in clinical practice;
c) develop good AI deployment practices (e.g., appropriate incorporation of AI in clinical practice, ethics, etc.), guidelines and recommendations to speed up the safe and effective deployment of AI in health;
d) test and evaluate through pilot projects how good deployment practices, guidelines and recommendations benefit diverse environments and diverse populations (e.g., metropolitan and rural hospitals). As part of the pilots, to analyse how clinical practice is changing with the incorporation of AI systems;
e) expand knowledge on AI uses in medicine and develop trust on AI by both healthcare professionals and public including patients;
f) prepare healthcare systems for full-sale application of AI;
g) educate relevant actors (e.g., healthcare professionals, hospital managers, AI developers, patients) on the best use and practices of AI deployment in healthcare;
h) educate individuals including patients on AI uses for diagnosis, treatment and management of patients;
i) provide a reference interactive digital tool to collect and communicate best AI deployment practices in healthcare and foster collaborations and communities; and
j) inform policy makers on the best way to accelerate the safe and effective deployment of AI in clinical practice.
22 January 2025 | Deadline for proposal submission |
Calls of the European Commission
Please find here the links to calls of the European Commission you can apply to: